Evidence map›Paper›PMID 30356083›Full record

ArticleScientific reports2018

Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence.

Claudia Alteri, Lavinia Fabeni, Rossana Scutari, Giulia Berno, Domenico Di Carlo, Caterina Gori, Ada Bertoli, Alessandra Vergori, Ilaria Mastrorosa, Rita Bellagamba and 12 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Claudia AlteriDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy. claudia.alteri@uniroma2.it.
Lavinia FabeniDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.
Rossana ScutariDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.
Giulia BernoNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Domenico Di CarloDepartment of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Pediatric Clinical Research Center "Romeo and Enrica Invernizzi", Milan, 20133, Italy.
Caterina GoriNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Ada BertoliDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.
Alessandra VergoriNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Ilaria MastrorosaNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Rita BellagambaNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Cristina MussiniUniversity Hospital of Modena, Modena, 41121, Italy.
Manuela ColafigliSan Gallicano Hospital, IFO-IRCCS, Rome, 00144, Italy.
Francesco MontellaSan Giovanni Hospital, Rome, 00184, Italy.
Alfredo PennicaSant'Andrea Hospital, Rome, 00189, Italy.
Claudio Maria MastroianniUniversity of Rome "La Sapienza", Rome, 00185, Italy.ORCID http://orcid.org/0000-0002-1286-467X
Enrico GirardiNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Massimo AndreoniUniversity Hospital of Rome "Tor Vergata", Rome, 00133, Italy.
Andrea AntinoriNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Valentina SvicherDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.
Francesca Ceccherini-SilbersteinDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.
Carlo Federico PernoNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, 00161, Italy.
Maria Mercedes SantoroDepartment of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Rome, 00133, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 is characterized by high genetic variability, with implications for spread, and immune-escape selection. Here, the genetic modification of HIV-1 B subtype over time was evaluated on 3,328 pol and 1,152 V3 sequences belonging to B subtype and collected from individuals diagnosed in Italy between 2003 and 2016. Sequences were analyzed for genetic-distance from consensus-B (Tajima-Nei), non-synonymous and synonymous rates (dN and dS), CTL escapes, and intra-host evolution over four time-spans (2003-2006, 2007-2009, 2010-2012, 2013-2016). Genetic-distance increased over time for both pol and V3 sequences (P < 0.0001 and 0.0003). Similar results were obtained for dN and dS. Entropy-value significantly increased at 16 pol and two V3 amino acid positions. Seven of them were CTL escape positions (protease: 71; reverse-transcriptase: 35, 162, 177, 202, 207, 211). Sequences with ≥3 CTL escapes increased from 36.1% in 2003-2006 to 54.0% in 2013-2016 (P < 0.0001), and showed better intra-host adaptation than those containing ≤2 CTL escapes (intra-host evolution: 3.0 × 10

Indexed as

Biological EvolutionAdaptation, BiologicalAdultFemaleHenipavirus InfectionsHIV-1HumansImmune EvasionItalyMaleMiddle AgedSequence Analysis, RNAT-Lymphocytes, Cytotoxic

Identifiers

PMID30356083
PMCPMC6200748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.